Analysis And Perspectives

apociii-inhibitors-for-shtg-and-fcs-treatment
Potential of APOCIII Inhibitors for Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Treatment

SHTG and FCS treatment market to evolve with the launch of ApoC-III inhibiting drugs, Olezarsen (Ionis) and ARO-APOC3 (Arrowhead). Clinical…

Find More
robotics-in-surgery
Robotics in Surgery: Has the Revolution Arrived?

With increasing MedTech companies, their products, & regulatory approvals, we can see increased adoption of robotics in surgery.

Find More
Orthopedic Implants Market Growth Analysis and Key Companies
Orthopedic Implants: Evaluating the Market Potential of the Unparalleled & Life-Saving Equipment

Orthopedic Implants Market is expected to grow at an immense pace. Companies are working to develop new implants to fulfill the demand

Find More
emerging-therapies-for-obesity-treatment
Obesity Treatment: Which Pipeline Therapy Will Revolutionize the Therapeutics Segment?

100+ pharma companies are working to assess challenges & seek opportunities that could influence obesity treatment scenario in coming years.

Find More
immune-oncology-therapeutics-for-cancer-treatment
Immuno-Oncology (I-O) Therapeutics: The Key to Future Cancer Treatment

Immuno-oncology (I-O) therapeutics, despite yielding effective outcomes, remain associated with a risk of failure & adverse side effects.

Find More
Artificial Intelligence in Drug Commercialization Market Outlook, Key Companies, and Products
Utilization of Artificial Intelligence for Drug Commercialization

The applications of Artificial Intelligence (AI) In Drug Commercialization is growing at an unprecedented rate. It provides several benefits

Find More
cancer-biomarkers-for-cancer-treatment
Cancer Biomarkers: Improving Treatment and Detection

Owning to evolution of genomic profiling technologies, cancer biomarkers are becoming increasingly relevant in management of cancer patients.

Find More
competitive-analysis-of-celmods-and-revlimid
CELMoDs – A Worthy Successor to REVLIMID?

BMS has established a comprehensive treatment strategy, with CELMODs replacing REVLIMID in earlier lines of multiple myeloma treatment.

Find More
Burn Ointment Market Trends, Developments, and Key Companies
Navigating the Key Trends and Major Advances in the Burn Ointment Market

Burn is one of the most severe and rapidly growing burdens worldwide, leading to a very high number of mortality and morbidity yearly. It can have intense physical, socioeconomic, and psychological consequences on the person and their family. As per the latest assessment by DelveInsight, incident cases of burns req...

Find More
acute-ischemic-stroke-treatment-outlook
Wider Administration Window – Need of the Moment for Acute Ischemic Stroke Patients

With a robust pipeline aiming to address the underserved market, the future of acute ischemic stroke treatment market holds much promise.

Find More